The development of a preference-based measure of health in children with atopic dermatitis

British Journal of Dermatology

Volumn 153, Issue 2, 2005, Pages 372-377

  Stevens, Katherine J ^a   Brazier, J E ^a   McKenna, S P ^c   Doward, L C ^c   Cork, M J ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c GALEN RESEARCH   (United Kingdom)

Author keywords

Atopic dermatitis; Children; Quality of life; Quality adjusted life years

Indexed keywords

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD HEALTH CARE; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; INTERVIEW; MALE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DERMATITIS, ATOPIC; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 24144453135     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06736.x     Document Type: Article

References (22)

1. Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 2001; 323:1300-3.
2. Guide to the Methods of Technology Appraisal. Draft for consultation, August 2003. National Institute for Clinical Excellence.
3. Drummond M. Economic Evaluation Alongside Clinical Trials. London: Department of Health, 1994.
4. Dolan P. Modelling valuations for EuroQol health states. Med Care 1997; 35:1095-108.
5. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions. Health Utilities Index. Pharmaco Economics 1995; 7:503-20.
6. Brazier J, Deverill M, Green C et al. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999; 3:i-iv, 1-164.
7. Lewis V, Finlay A. 10 years experience of the Dermatology Life Quality Index (DLQI). J Invest Dermatol Symp Proc 2004; 9:169-80.
8. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997; 76:159-62.
9. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132:942-9.
10. Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev 1956; 63:81-97.
11. Brazier J, Dixon S. The use of condition specific outcome measures in economic appraisal. Health Econ 1995; 4:255-64.
12. McKenna SP, Doward LC, Niero M, Erdman R. Development of needs-based quality of life instruments. Value Health 2004; 7 (Suppl. 1):S17-21.
13. Whalley D, McKenna SP, Dewar AL et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004; 150:274-83.
14. Whalley D, Huels J, McKenna SP, van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. Pediatrics 2002; 110:1133-6.
15. Guidance for Manufacturers and Sponsors. National Institute for Clinical Excellence. Technology Appraisals Process Series no. 5 June 2001. London: National Institute for Clinical Excellence.
16. http://www.afd.co.uk/names.asp; accessed 9 March 2005.
17. McCabe C, Stevens K, Roberts J, Brazier J. Health state values for the HUI 2 descriptive system: results from a UK survey. Health Econ 2005; 14:231-44.
18. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21:271-92.
19. http://www.statistics.gov.uk/census2001/pop2001/england_ages.asp; accessed 8 March 2005.
20. http://www.statistics.gov.uk/census2001/profiles/64-A.asp; accessed 8 March 2005.
21. Feeny DH, Leiper A, Barr RD et al. The comprehensive assessment of health status in survivors of childhood cancer: application to high risk acute lymphoblastic leukaemia. Br J Cancer 1993; 67:1047-52.
22. Chen SC, Bayoumi AM, Soon SL et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Invest Dermatol Symp Proc 2004; 9:160-8.